Source link : https://newshealth.biz/health-news/trop2-drug-extends-survival-in-egfr-mutated-lung-cancer/
(MedPage Today) — BERLIN — An antibody-drug conjugate targeting Trop2 significantly improved survival outcomes compared with platinum-based chemotherapy in pretreated patients with EGFR-mutated non-small cell lung cancer (NSCLC), a randomized… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118028 Author : Publish date : 2025-10-20 14:57:00 Copyright for syndicated content belongs to the linked Source.
The post Trop2 Drug Extends Survival in EGFR-Mutated Lung Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-20 14:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8